First Patient Dosed Clinical Trial Commemorative

First Patient Dosed Clinical Trial Commemorative

Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, theĀ  drug is intended for the treatment of obstructive sleep apnea. (23AZH173)

Side view of Lucite commemorative recognizing a clinical study of a sleep apnea therapy.